Bristol-Myers Squibb has signed an agreement with Avista Capital Partners, a private equity firm, to sell BMS Medical Imaging for $525 million. BMS MI is a leading supplier of medical imaging products for nuclear and ultrasound cardiovascular diagnostic imaging procedures. “As Bristol-Myers Squibb continues to focus on evolving into a next- generation BioPharma company, we determined the best way to maximize the value of Medical Imaging for shareholders was to sell this business and rei...